These products offer a holistic approach to health, focusing on improving your gut microbiome to achieve sustainable results
This area needs to be explored and is still not completely addressed to overcome the drawbacks
Future large-scale, well-designed clinical trials will be essential to confirm their therapeutic potential, clarify the contribution of metabolic versus immunological effects, and define their role within the treatment algorithm of PsO and PsA
Eli Lilly manufactures retatrutide and also markets tirzepatide (Zepbound/Mounjaro), which is the closest available comparator as a multi-receptor agonist
In 2021, Kishimoto et al., in a double-blind, placebo-controlled clinical trial, evaluated the anti-inflammatory effects of curcuRouge for 4 weeks on systemic inflammation in adults over 60 years of age in Japan [62]